Arrowhead Pharmaceuticals, Inc. ( ARWR) - Key Metrics
ARWR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | $1.89 | $0.22 | $0.10 | $0.08 |
| 2025Q4 | $1.89 | -$0.18 | $0.15 | $0.10 |
| 2025Q3 | $0.20 | -$1.26 | -$1.11 | -$1.13 |
| 2025Q2 | $4.07 | $2.78 | $3.45 | $3.41 |
ARWR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | 75.44 |
| 2025Q4 | ? | -49.27 |
| 2025Q3 | ? | -3.13 |
| 2025Q2 | ? | 1.15 |
ARWR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.92% | ? |
| 2026Q1 | 0.12% | ? |
| 2025Q4 | 0.28% | ? |
| 2025Q3 | -7.15% | ? |
| 2025Q2 | 26.77% | ? |
ARWR
Price: $76.82
52 week price:
Earnings Per Share: -2.24 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 594870
Ebitda: -12.7 millionMarket Capitalization: 10.0 billion